Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Dec, 2015 | Pubmed ID: 26541272